4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-25-000005
Chief Scientific Officer gave up 3,643 shares (to pay taxes)
- Chief Scientific Officer acquired 8,865 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Humeau Laurent · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Exercise or conversion : show line 1 in the form | +3,855 | 28,192 | D | ||
| 2025-02-26 | Shares withheld for taxes : show line 2 in the form | −1,584 | $1.98 | $3,136 | 26,608 | D |
| 2025-02-26 | Exercise or conversion : show line 3 in the form | +5,010 | 31,618 | D | ||
| 2025-02-26 | Shares withheld for taxes : show line 4 in the form | −2,059 | $1.98 | $4,077 | 29,559 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-26 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −3,855 | 0 | D |
| 2025-02-26 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −5,010 | 10,019 | D |
| 2025-02-27 | Grant or award : show line 7 in the form Common Stock Option | +27,402 | 27,402 | D |
| 2025-02-27 | Grant or award : show line 8 in the form Restricted Stock Unit | +22,098 | 22,098 | D |
Loading xslF345X05/wk-form4_1740783954.xml…